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As the number of applications for polymers in pharmaceutical development is increasing, there 
is need for fundamental understanding on how such compounds behave during tableting. This 
research is focussed on the tableting behaviour of amorphous polymers, their solid dispersions 
and the impact of hot-melt extrusion on the compaction properties of these materials. Soluplus, 
Kollidon VA 64 and Eudragit EPO were selected as amorphous polymers since these are 
widely studied carriers for solid dispersions, while Celecoxib was chosen as BCS class II model 
drug. Neat polymers and physical mixtures (up to 35% drug load) were processed by hot-melt 
extrusion (HME), milled and sieved to obtain powders with comparable particle sizes as the 
neat polymer. A novel approach was used for in-line analysis of the compaction properties on 
a rotary tablet press (Modul P, GEA) using complementary sensors and software (CDAAS, 
GEA). By combining ‘in-die’ and ‘out-of-die’ techniques, it was possible to investigate in a 
comprehensive way the impact of HME on the tableting behaviour of amorphous polymers and 
their formulations. The formation of stable glassy solutions altered the formulations towards 
more fragmentary behaviour under compression which was beneficial for the tabletability. 
Principal component analysis (PCA) was applied to summarize the behaviour during 
compaction of the formulations, enabling the selection of Soluplus and Kollidon VA 64 as the 
most favourable polymers for compaction of glassy solutions.  
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1.    INTRODUCTION 
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The interest in biocompatible polymers as substantial components of pharmaceutical 
formulations is currently growing since they carry a broad spectrum of applications (e.g. 
pharmaceutical binders, diluents, disintegrants, film coating, release controlling agents and 
precipitation inhibitors) and can be modified for specific usage (Claeys et al., 2014; Fonteyne 
et al., 2014; Kadajji and Betageri, 2011; Pillay et al., 2013; Warren et al., 2013; Yang et al., 
2010). Furthermore, polymers have been successfully used as stabilizing carriers in solid 
dispersion manufacturing, a drug formulation that has received a lot of attention in the past few 
years. The main purpose of formulating a drug as solid dispersion is to ameliorate the 
bioavailability, since new drug molecules are often poorly water-soluble. Altering the physical 
state of the active pharmaceutical ingredient (API) by processing it within a polymeric carrier 
(i.e. solid dispersion) proved to be a viable technique to overcome solubility-related problems 
(Janssens and Van den Mooter, 2009; Leuner and Dressman, 2000; Vo et al., 2013).  
Hot-melt extrusion (HME) is an efficient, continuous process for the manufacturing of 
solid dispersions as the polymer and API are simultaneously fed into a heated barrel with 
screws. The combination of heat, mixing, shear and transport finally results in a homogeneous 
melt in which the drug is preferably molecularly dispersed in the polymer matrix (Sarode et al., 
2013; Shah et al., 2013). In respect to dissolution properties, amorphous (glassy) solutions are 
preferred as they represent the most energetic solid state of a material and therefore 
amorphous polymers are often used as carrier in solid dispersions (Van Den Mooter, 2012). 
Downstream processing of the strand-like extrudates by milling and tableting is still one of the 
preferred techniques to process hot-melt extruded formulations into their final dosage forms 
(Treffer et al., 2013).   
Although there have been many studies on HME and amorphous solid dispersions, 
there is still limited knowledge on how processing techniques might influence the downstream 
processing such as the tableting behaviour of pharmaceutical polymers and their formulations 
(Agrawal et al., 2013; Boersen et al., 2013; Iyer et al., 2013). However, this is a fundamental 
aspect since it acquires crucial knowledge indispensable for further formulation development. 
In a previous article (Grymonpré et al., 2016) we illustrated via ‘out-of-die’ methods that HME 
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altered the mechanical properties of polyvinyl alcohol (PVA, a semi-crystalline polymer), mostly 
since the physical state of the polymer itself was changed during HME. As amorphous 
polymers were used in current study, this phenomenon could not occur and evaluating these 
polymers is therefore beneficial for fundamental investigation of the impact of HME on 
polymers.  
Traditionally, compaction simulators which are designed to simulate the compaction 
process in a rotary tablet press are used for characterizing ‘in-die’ compaction properties of 
pharmaceutical materials (Michaut et al., 2010). Although these devices are versatile and allow 
in-depth analysis of compaction mechanisms, complex simulations are often necessary for 
understanding the behaviour in a specific rotary tablet press. Therefore, an experimental 
approach was developed to monitor and analyse ‘in-die’ compaction properties of amorphous 
polymers and their solid dispersions on a rotary tablet press. It is intended with this research 
study to validate the feasibility of performing in-line measurements during the tableting 
process. The relationships in the compaction data were highlighted using PCA in order 
to establish a formulation development platform of HME processed materials for 
tableting purpose.  
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2.    MATERIALS AND METHODS 
2.1.  Materials  
Three commonly used amorphous polymers were selected for this study. Soluplus (SOL) 
and Kollidon VA 64 (VA 64) were a gift from BASF (Ludwigshafen, Germany) while Eudragit 
EPO (EPO) was donated by Evonik (Darmstadt, Germany). Celecoxib (CEL, Utag, 
Amsterdam, The Netherlands), a BCS class II drug, was used as model drug.  
2.2.   Characterization  
2.2.1. Thermal analysis  
Thermogravimetric analysis (TGA 2950, TA instruments, Leatherhead, UK) was 
conducted on all polymers and CEL to investigate the thermal stability. Samples ( 15 mg) 
were heated up to 600 °C after equilibration at 25 °C using a heating rate of 10 °C/min. 
 All materials were analysed via modulated differential scanning calorimetry (MDSC) 
(Q2000, TA Instruments, Leatherhead, UK) to detect glass transition temperatures (Tg) and 
melting points (Tm) using a heating rate of 2 °C/min and a modulation of 0.318 °C/min over 3 
cycles (heat/cool/heat) from -20 °C to 200 °C. The (M)DSC cell was purged with dry nitrogen 
at a flow rate of 50 ml/min. All results were analysed in triplicate using the TA instruments 
Universal Analysis 2000 software. Additional MDSC-measurements (2 cycles) were performed 
both after HME and milling in order to verify the solid state properties of all formulations after 
each processing step. A one-way analysis of variance (ANOVA) was performed with SPSS 
Statistics 23 (IBM, New York, United States) to detect significant differences in Tg after 
extrusion or milling. A Shapiro-Wilk test was performed to verify normality and the homogeneity 
of variances was tested by Levene statistics. Tukey analysis was used to determine differences 
in Tg and Tm between non-processing, extrusion or milling.   
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2.2.2. X-ray diffraction  
X-ray Diffraction patterns (XRD) were recorded to investigate the crystallinity of the 
formulations before and after HME/milling using a D5000 CU K diffractor (=0.154 nm) 
(Siemens, Karlsruhe, Germany) with a voltage of 40 V in the angular range of 10 ° < 2 < 20 ° 
using a step scan mode (step width = 0.02 °, counting time = 1 s/step). 
2.2.3. Fourier-transform infrared spectrometry  
Attenuated total reflection Fourier-transform infrared (ATR FT-IR) spectrometry 
(Thermo Fisher Scientific, Nicolet iS5, Massachusetts, USA) was applied to examine 
interactions between polymers and API. Spectra (n=3) were collected in the 4000-550 cm-1 
range with a resolution of 4 cm-1 and averaged over 64 scans for all formulations (neat 
polymers, polymer-API physical mixtures and milled solid dispersions). SIMCA 13.0.3 software 
(Umetrics, Umeå, Sweden) was used for data analysis and standard normal variate (SNV) pre-
processing of the FT-IR spectra.  
2.2.4. Particle size distribution 
Particle size distribution (PSD) of the powders was recorded (n=3) by laser diffraction 
(Mastersizer-S long bench, Malvern Instruments, Malvern, UK) via a dry dispersion method in 
volumetrical distribution mode using a 300 RF lens combined with a dry powder feeder at a 
feeding rate of 3.0 G and a jet pressure of 2.0 bar (Malvern Instruments, Malvern, UK). 
2.2.5. Helium pycnometry   
True density of all powders was measured (n=3) using helium pycnometry (AccuPyc 
1330, Micromeritics, Norcross, USA) at an equilibration rate of 0.0050 psig/min with the 
number of purges set to 10. Calibration was performed between the formulations. 
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2.2.6. Moisture content  
Immediately before tabletting, loss on drying (LOD) was performed (n=3) on all 
formulations to determine residual moisture content using a Mettler LP16 moisture analyser, 
including an infrared dryer and a Mettler PM460 balance (Mettler-Toledo, Zaventem, Belgium). 
Approximately 1 g of sample was dried at 105 °C until the rate of change was less than 0.1% 
w/w for 30 s.  
2.2.7. Specific surface area   
Specific surface area (SSA) of the powders was measured using krypton gas 
adsorption (ASAP 2420, Micromeritics, Norcross, USA) with multipoint BET (Brunnauer, 
Emmett, and Teller) calculations per ISO 9277. All samples were outgassed under vacuum at 
25 °C for 960 minutes to remove any gases and vapours that may have adsorbed on the 
surface. The relative pressures (P/P0) during the measurements ranged from 0.05 to 0.25 (11 
datapoints) at a temperature of -196 °C and an equilibration interval of 10s.  
2.2.8. Powder flowability  
The flow rate of all formulations was determined using a flowability testing device 
(FlowPro, IPAT, Finland) which consists of a frame, sample holder (5.96 ml) with orifice (3.0 
mm) and an analytical scale. Vertical oscillations of the sample holder break the cohesive 
forces in the powder bed and allow the powder to flow through the orifice. The mass discharged 
from the sample holder is measured over time in order to calculate the flow rate (mg/s) (Sandler 
et al., 2010). 5% of the mass flow function at the beginning and at the end was not taken into 
account to minimize the non-linearity of the mass flow (Seppälä et al., 2010). All samples were 
measured in triplicate.   
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2.3.  Screening drug load capacity  
Physical mixtures of each polymer and CEL were made with mortar and pestle, and 
afterwards extruded on a co-rotating twin-screw extruder (Haake MiniLab II Micro 
Compounder, Thermo Electron, Karlsruhe, Germany) at a screw speed of 70 rpm and different 
processing temperatures (130 °C for EPO-mixtures; 150 °C for SOL-mixtures and 160 °C for 
VA 64-mixtures). Modulated differential scanning calorimetry (MDSC) was used for solid state 
characterization of the resulting extrudates and detecting the maximal solubilising capacity of 
each polymer for the drug.  
 
2.4. Rheological screening for hot-melt extrusion  
 Rheological properties of all polymers and their physical mixtures (35% CEL, w/w) were 
determined with a Thermo Scientific HAAKE MARS III (Modular Advanced Rheometer System, 
Thermo Fisher Scientific, Karlsruhe, Germany) in order to predict the extrudable temperature 
range for each formulation. A parallel plate (d = 20 mm) geometrical set-up was used and all 
measurements were done in a control deformation auto strain mode. At first, an amplitude 
sweep was performed on all samples to determine the linear viscoelastic region. Afterwards, 
the samples were loaded at 90 °C and equilibrated for 5 min to perform a temperature sweep. 
All samples were gradually heated at 2 °C/min with an angular frequency of 1 Hz and a strain 
rate of 1% (for SOL and VA 64 - mixtures) or 5% (for EPO mixtures) in order to determine the 
temperature range for which the complex viscosity (*) is between 1000 and 10000 Pa s (Gupta 
et al., 2015; Verstraete et al., 2016).   
 
2.5.   Hot-melt extrusion  
 Both neat polymers and their physical mixtures (containing 35% CEL, w/w) were 
extruded using a co-rotating, fully intermeshing twin-screw extruder (Prism Eurolab 16, Thermo 
Fisher, Germany) equipped with two co-rotating twin-screws with 3 mixing zones, a cylindrical 
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die of 3 mm and a DD flexwall 18 feeder (Brabender Technology, Germany), which was set 
in its gravimetric feeding mode. HME was conducted at a screw-speed of 75 rpm and barrel 
temperatures depending on the rheological screening (Table 1). The resulting extrudates were 
milled after cooling using a knife mill (Moulinex AR110510, France) and sieved towards equal 
particle sizes as the neat non-processed polymers.  
 
2.6. Tableting 
For each polymer, 3 formulations (neat polymer, neat polymer extrudates and extrudates 
of polymer-CEL (35%)) were compressed to tablets on a rotary tablet press (MODULTM P, GEA 
Pharma Systems, CourtoyTM, Halle, Belgium) equipped with cylindrical flat-faced Euro B 
punches of 10 mm diameter and an overfill cam of 16 mm. Tablets (270  10 mg) were 
compressed on 6 different main compaction pressures: 65, 130, 190, 255, 380 and 510 MPa 
without the use of a pre-compression step at a turret speed of 5 rpm. All tablets were analysed 
for ‘out-of-die’ properties (tablet strength, dimensions and mass) immediately after ejection. 
Punch deformation at each compaction pressure was calculated and corrected for during this 
study. Tableting and tablet characterization was performed in a climatic chamber, for which 
the temperature and relative humidity were recorded at 24.7 ( 0.6) °C and 36.4 ( 1.5)% 
respectively.  
In-die measurements of the compaction properties was performed by linear variable 
displacement transducers (LVDT) incorporated inside the turret and clamped onto one pair of 
punches enabling the monitoring of punch stroke movements during a compression cycle 
(GEA Pharma Systems, Halle, Belgium). Calibration was done previous to each formulation, 
by interpolating the output voltage of the sensor to physical values during static measurements. 
A wireless transmission system continuously transmitted the data from these sensors to a data 
acquisition and analysis system (CDAAS, GEA Pharma Systems, Halle, Belgium). 
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2.7. Compaction process evaluation  
2.7.1.  ‘Out-of-die’ measurements  
Tablet diametrical tensile strength was calculated according to following equation (Fell, 
J.T.; Newton, 1968):    
          Tablet	Tensile	Strength	ሺσt	ሻ	ൌ	 ଶ௉గ஽௧                      (1) 
where P, D and t denotes tablet diametral breaking force (N), tablet diameter (mm) and tablet 
thickness (mm), respectively, which are determined using a hardness tester (Sotax HT10, 
Basel, Switzerland).  
In order to determine the porosity of the compacts following equation is used:  
     Tablet	Porosity	ൌ	1 െ	 	ఘೌ೛೛	ఘ೟ೝೠ೐                        (2) 
where ρapp and ρtrue denote the apparent and true density (g/ml), respectively. The latter was 
measured using helium pycnometry (AccuPyc 1330, Micrometrics, Norcross, USA), while the 
apparent density was calculated by dividing the tablet mass by the volume of the tablet.  
 
Tabletability and compressibility profiles of each formulation were analysed by plotting 
tablet tensile strength and porosity, respectively, in function of the main compaction pressure. 
Compactibility of the formulations was assessed by plotting log tensile strength in function of 
tablet porosity, a relationship that was described by (Ryshkewitch, 1953):  
     	ߪ௧ ൌ 	ߪ଴	݁ି௕௉           (3) 
where σt and ߪ଴ denotes the tablet tensile strength (MPa) and limiting tablet tensile strength at 
zero porosity (MPa), respectively, b is an empirical constant and P denotes the tablet porosity.  
‘Out-of-die’ axial recovery (AR) of the compacts was calculated based on following 
equation (Armstrong and Haines-Nutt, 1972):   
                 ܣܴ	ሺ%ሻ ൌ ቀ	்௔ି	்௜ௗ்௜ௗ ቁ ݔ100             (4) 
for which Tid represents the minimal tablet thickness (mm) under maximal compression force 
‘in-die’ and Ta is the tablet thickness (mm) measured immediately after ejection and after 7 
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days of storage in hermetic sealed aluminium bags (AR7) by use of a validated micrometre 
screw.  
2.7.2. ‘In-die’ measurements  
Measuring the punch stroke movement during compression on the instrumented rotary 
tablet press enabled plotting of the compression cycles, taking into account the compaction 
force and the punch separation (i.e. force-displacement curves, Fig. 1). During a compression 
cycle on a rotary tablet press, upper and lower punch are moving towards each other inducing 
consolidation of the powder bed. In a first phase (A-A’), the powder particles are rearranged 
and packed without any measurable increase in compression force up to a second phase (A’-
B) that is characterised by an augmentation of compression force until a maximal force is 
reached (B) correlating with minimal separation between upper and lower punch (C, i.e. 
minimal tablet thickness). During this second phase, particle fragmentation, plastic deformation 
and rearrangement occurs (depending on the material properties), resulting in varying degrees 
of particle consolidation. The final phase of the compression cycle (B-D) is marked by a 
progressive release of applied stress where a period of elastic recovery (i.e. dissipation of 
stored elastic energy) by the compact can re-enlarge the distance between upper and lower 
punch (D).  
Energy consumption or dissipation (J/g) at each phase can be calculated from the area 
under the curve:  
                     ܧ ൌ 	׬ ܨ	݄݀          (5) 
where F denotes the compression force (kN) and h the punch separation (mm). All energies 
are normalised by taking the compact mass into account to allow comparison between the 
different formulations.   
 
 The integral calculus from A’ to C (Fig. 1) corresponds to the specific total energy 
(A’BD) involved in compression excluding packing and frictions (A-A’), used for fragmentation 
and deformation which induce interparticulate bonding. The specific expansion energy (i.e. 
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energy lost by instantaneous (in-die) elastic recovery of the compact, BCD) is calculated by 
integration from C to D (Fig. 1). The difference between total energy and expansion energy 
defines the (specific) net energy during compaction (A’BD) (Busignies et al., 2004; Michaut et 
al., 2010; Pontier et al., 2002; Rodriguez and Chulia, 2005; Vachon and Chulia, 1999). 
The resulting energies are used for calculation of two specific compaction properties:  
‐ A plasticity factor (PF) which represents the energy of compaction used for plastic 
deformation and fragmentation:  
    ܲܨ	ሺ%ሻ ൌ 	 ௡௘௧	௘௡௘௥௚௬௧௢௧௔௟	௘௡௘௥௚௬ 	ݔ	100                  (6) 
‐ ‘In-die’ axial recovery (IAR) which represents the elasticity of a material:  
    ܫܣܴ	ሺ%ሻ ൌ 	 ்ௗି்௖்௖ 	ݔ	100         (7) 
where Td and Tc represents the punch separation after decompression (point D at Fig. 
1) and the minimal punch separation during compression (point C at Fig. 1), 
respectively.   
All calculations for in-line measuring of the compaction properties were done using the CDAAS 
software (GEA Pharma Systems, Halle, Belgium) on at least 3 compacts for each formulation.  
Using the ‘in-die’ data of the CDAAS system, Heckel analysis was performed on all 
formulations using the data at a compaction pressure of approximately 65 MPa. The theory of 
Shapiro-Konopicky-Heckel is based on following equation (Heckel, 1961):  
     ݈݊	 ଵா ൌ ܭܲ ൅ ܣ                     (8) 
where E is the porosity of the powder bed at a compaction pressure P, K is the slope of the 
linear part of the plot (with the best R2 fit) and A is the Y intercept with the linear part of the 
plot. The mean Heckel yield pressures (Py) are given by the reciprocal values K, while the 
intercept of both the linear part of the plot (A) and the non-linear part (I) are used to calculate 
Da, DI.  
   Da	ሺIሻ	ൌ	1‐	݁ି஺	ሺூሻ		 	 	 	 	 					(9)	
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The difference between Da and DI denotes Db, which describes the reduction in volume due to 
rearrangement of the particles since A is said to reflect low pressure densification by 
interparticulate motion (Tarlier et al., 2015).  
   Db	ൌ	Da	–	DI	 	 	 	 	 	 					(10)  
	
2.8. Multivariate data analysis  
Principal component analysis (PCA) was executed on the relevant compaction data in 
order to classify the different materials according to their compaction behaviour by using the 
multivariate data analysing software SIMCA 13.0.3 (Umetrics, Umeå, Sweden). PCA is a 
multivariate projection method which extracts and displays the variation in the data set (Pieters 
et al., 2013).  Highly correlated original variables, e.g. relevant compaction and mechanical 
properties of the formulations, are transformed into a new system of latent variables called 
principal components (PCs) which are sequentially acquired by an orthogonal, bilinear 
decomposition of the data matrix. PCs are composed of a scores and a loading vector. The 
loading vector provides qualitative information about which properties in the original 
observations are captured by the corresponding component, while the scores (i.e. the 
associated weighted averages of the original variables) provide quantitative information on 
how the different materials behave under compaction. The data were pre-processed by unit 
variate scaling and centered in order to balance the weight of each variable. 
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3.    RESULTS AND DISCUSSION 
3.1.  Material characterization & extrusion screening 
TGA indicated that all components of the formulations were thermally stable at the 
temperatures used in HME as degradation of the most sensitive component (CEL) occurred 
from 242 °C (Table 1) and extrusion temperatures of the formulations containing CEL did not 
exceed 150 °C. MDSC measurements confirmed that all polymers were amorphous, while a 
melting endotherm was detected for CEL around 162 °C. Rheological properties of the 
formulations were investigated in order to predict the required HME temperatures, as this 
approach was more effective compared to predictions based on MDSC data since the samples 
are additionally subjected to shear stresses during the rheology measurements (Gupta, 2014). 
Gupta et al. stated that the temperature range where the melt viscosity of a polymer ranges 
between 1000 and 10000 Pa s is the most suitable region for melt extrusion (Gupta et al., 
2015). This region was determined by linking observed torque values during HME with the 
complex viscosity of SOL-formulations. Using temperature sweeps experiments (Fig. 2), the 
extrudable regions were established for the amorphous polymers used in this study and based 
on these data the barrel temperatures for the HME experiments were determined (Table 1). 
Maximal solubilising capacity of each polymer for CEL was screened by MDSC-
measurements on the extrudates. Up to 35% of CEL could be dispersed in all polymer carriers 
while obtaining stable glassy solutions, since no melting endotherm appeared in the 
thermograms and only one Tg was present. At higher drug loads CEL melting peaks were 
detected.   
  
 
 
3.2.  Solid state characterization  
MDSC analysis was used to examine the influence of extrusion and milling on the solid 
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state physicochemical properties of the intermediate products (Table 2). ANOVA showed a 
significant (p<0.05) drop in polymer Tg after HME of the neat polymers, a phenomenon that 
has been linked to an increase in free volume between the polymer strains due to the shear 
stress (Pae and Pressure, 1986). This was significant for SOL and EPO, since they have a 
lower Tg and therefore a less rigid structure compared to VA 64. Milling did not have a 
significant (p>0.05) influence on Tg for all formulations.  
Processing the physical mixtures (PM) of all polymers with CEL by HME yielded glassy 
solutions with a single Tg. However, the presence of only one Tg does not necessarily indicates 
drug-polymer miscibility since the Tg of CEL and SOL/EPO were close to each other (Van Den 
Mooter, 2012). Therefore, additional XRD-analysis and FT-IR spectrometry was applied on the 
formulations in order to distinguish between the solid dispersion type. X-ray diffraction patterns 
confirmed the absence of crystalline content (typical amorphous halo) in solid dispersions of 
SOL, VA 64 and EPO (c, e, g respectively in Fig. 3) compared to their non-processed physical 
mixtures (b, d, f respectively in Fig. 3).  
FT-IR measurements were used to identify possible molecular interactions between 
drug (CEL) and polymers after HME, which is an indication for good stabilizing properties of 
the carriers. Relevant parts of the FT-IR spectra were the stretching vibrations in the area from 
3500 till 2800 cm-1, as highlighted in Fig.  4 for SOL-formulations. A specific fingerprint of CEL 
was detected in the physical mixtures with abundant bands at 3333, 3227 and 3062 cm-1 (Fig. 
4). The sharp doublet at 3333 cm-1 and 3227 cm-1 is attributed to the N-H stretching vibration 
of the -SO2NH2 group of CEL. This doublet was clearly diminished and broadened after HME, 
suggesting that the sulphonamide group of CEL acted as H-donor and engaged in interactions 
with –C=O carbonyl groups (H-acceptors) of the polymer (Fouad et al., 2011; Gupta et al., 
2005). Similar spectra were obtained for the solid dispersions with VA 64 and EPO (data not 
shown), which were in line with earlier findings linking this spectra to the formation of an 
amorphous drug form and possible molecular interactions between CEL and the carriers 
(Albers et al., 2009), favouring stability of the formulation. By combining the data from MDSC, 
XRD and FT-IR measurements, it was concluded that HME resulted in the formation of glassy 
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solutions.  
Accelerated stability tests were conducted on the glassy solutions under stress 
conditions (40 °C and 75% relative humidity) as described by the ICH Q1A (R2) guidelines. 
Glassy solutions of all formulations containing 35% of CEL (milled extrudates) were stable for 
at least 6 months under these conditions since MDSC revealed no reappearance of the Tm 
specific for CEL. These results emphasized that the selected amorphous polymers were 
suitable carriers for solid dispersions with CEL as they had sufficient stabilizing properties. 
 
3.3. Powder characterization  
Before tableting, all powders (neat polymers and milled extrudates) were investigated 
on their true density, moisture content, particle size distribution, specific surface area and 
flowability since these could impact the tableting behaviour of the formulations (Table 3). LOD 
measurements revealed no significant differences in moisture content between the neat 
polymers and the processed formulations (i.e. milled extrudates), which was beneficial for this 
study since these results excluded the moisture content as a confounding factor during 
analysis of the tableting behaviour of the formulations. During the study, it was essential to 
limit differences in PSD in order to be able to compare similar formulations on their tableting 
behaviour before and after HME processing. Therefore, the milled extrudates were extensively 
sieved to obtain a PSD similar to the neat polymer.   
When comparing specific surface areas of the samples, most variation was noticed 
between the polymer types which could be explained by differences in PSD between 
formulations of SOL, VA 64 and EPO. However, particle size and surface area are not 
completely interchangeable since this correlation is also dependent on the shape of the 
particles.  
Flowability of the powders was mainly dependent on the mean PSD (Table 3). With 
respect to flowability, the polymers are ranked in the following decreasing order: SOL, VA 64 
and EPO. Impact of the processing steps on the flowability of formulations within one polymer 
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was small, suggesting that the flowability of the formulations mainly depended on the initial 
flow properties of the neat polymer.  
 
3.4.  Tablet properties  
3.4.1.  ‘Out-of-die’ measurements   
The impact of HME on the tabletability of the formulations is shown in Fig. 5, which 
describes the ability of a material to form compacts with a certain tensile strength in function 
of the compaction pressure. Briefly, tablet tensile strength increased when higher pressures 
were exerted on the powder bed until a certain point where, material-depending, the stored 
elastic energy of the materials caused a level-off (i.e. plateau phase) in the profile (Sun, 2011). 
When analysing tabletability plots, both the relative positioning of the curves (i.e. maximal 
tabletability) and more importantly the shape of the curves (i.e. inflection point for level-off) 
should receive attention, since the latter indicates whether changes in mechanical properties 
have occurred during HME (Grymonpré et al., 2016). The largest influence of HME on the 
tabletability profiles was noticed for formulations containing SOL and EPO (Fig. 5). In general, 
tablets with higher tensile strength were obtained when tableting glassy solutions (polymer-
CEL) compared to tablets of the neat polymer or their extrudates, except for glassy solutions 
of VA 64 which yielded tablets with low tensile strength at low forces.  Additionally, differences 
were obtained in the curve-shape of the glassy solutions as maximum tabletability was reached 
at higher compaction pressures, indicating altered mechanical properties for this formulation, 
while HME had no impact on this parameter for the neat polymer (i.e. similar curve-shape for 
the neat polymer and their extrudates). Tablets of SOL-extrudates have slightly lower tensile 
strengths compared to tablets of the non-processed polymer although the shape of the curve 
remains the same. This could be due to small changes in the bonding area (reflected by the 
compressibility) and/or changes in the bonding strength per unit bonding area (reflected by the 
compactibility).   
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Compressibility plots describe the ability of a material to reduce its volume as result of 
an applied pressure and can be used for comparing the tendency of a formulation to create 
sufficient interparticulate bonding area (i.e. lower porosity) under pressure (Sun and Grant, 
2001). When analysing the compressibility profiles (Fig. 6), slightly lower porosities were 
obtained for tablets of EPO-extrudates, indicating higher interparticulate bonding areas which 
could explain the higher tabletability for this formulation in combination with the higher specific 
surface areas measured for this formulation (Table 3). No significant differences in 
compressibility were detected for formulations with SOL and VA 64. Therefore, the lower 
tabletability of SOL-extrudates could not be attributed to lower interparticulate bonding areas 
for this formulation.  
Tablet tensile strength decreases exponentially with increasing porosity as formulated 
in the Ryshkewitch equation (Ryshkewitch, 1953) and is described by the compactibility (Fig. 
7) as a measure for the bonding strength per unit bonding area. By analysing compactibility, 
the origin of the differences in tablet tensile strength for SOL-formulation was detected, since 
extrudates of SOL showed lower interparticulate bonding strength at a specific porosity 
compared to the neat polymer and the glassy solutions. The compactibility plots for VA 64 and 
EPO were in line with the tabletability plots, a better compactibility for glassy solutions at lower 
porosities (i.e. higher compaction pressures).  
Simultaneously investigating compressibility and compactibility of the formulations 
enabled to explain the differences observed in the relative positioning of the tabletability plots. 
In general, the higher tablet tensile strengths observed for glassy solutions formulated with all 
polymers were due to higher interparticulate bonding strengths per unit bonding area (i.e. 
compactibility), while no changes were detected in the interparticulate bonding areas between 
formulations. However, these ‘out-of-die’ techniques could not fully explain the altered shape 
of the tabletability curves, which are indicative of a modified compaction behaviour, and did 
not resulted in a comprehensive understanding of the formation of higher interparticulate 
bonding strengths. Therefore, there was need for analysing the compaction properties of these 
formulations to understand the mechanisms which modified the mechanical properties such 
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as tablet tensile strength. These compaction properties focus more on how a material uses the 
energy provided during the different stages of a compression cycle, by analysing energy plots 
(i.e. force-displacement curves) of the formulations (Busignies et al., 2004).  
3.4.2.  ‘In-die’ measurements  
During this study an experimental approach was used to measure the ‘in-die’ 
compaction properties of formulations containing amorphous polymers immediately on a fully 
instrumented rotary tablet press. Fig.  8 displays the plasticity factor, which represents the 
energy used during compaction for plastic deformation and fragmentation, in function of the 
compaction pressure exerted on the powder bed.  
Although two completely independent data sets were used, there was a remarkably 
good correlation between these plasticity factor profiles and the tabletability plots of the same 
formulations. For SOL-formulations, the plasticity factor of the glassy solutions started to 
deviate from the neat and extruded polymer at 190 MPa (Fig. 8, left), similar to the compaction 
pressure at which differences in tablet tensile strength started to occur between the SOL 
formulations (Fig. 5, left). Similar correlations between the plasticity factor profiles and 
tabletability plots were observed for VA 64 and EPO formulations. At higher compaction 
pressures, glassy solutions of SOL and EPO underwent more plastic deformation which could 
explain the higher compactibility and tabletability of this formulations, while glassy solutions of 
VA 64 initially underwent less plastic deformation at lower compaction pressures which was 
correlated with the tabletability plots of this polymer. No differences in plasticity factor were 
detected between tableting the neat polymers and their extrudates, indicating that HME did not 
alter the volume reduction mechanisms of the amorphous polymers when no API is included. 
 
Fig.  9 shows the measured in-die elastic recovery (IER), which represents the elasticity 
of a material, plotted against the compaction pressure. If a material has more elastic properties 
it can release the stored elastic energy from compression during the decompression phase, 
thereby causing disruption of some previously formed interparticulate bondings, resulting in a 
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higher IER and often lower tablet tensile strength (i.e. plateau phase in tabletability). More 
elastic recovery during decompression was recorded at higher compaction pressures since 
more energy is provided to be stored by the particles as elastic energy. No differences in IER 
were noticed between SOL and VA 64-containing formulations, while a significantly lower IER 
was obtained for glassy solutions of EPO compared to the neat polymer and its extrudates. 
This could contribute to the higher tabletability of EPO-glassy solutions since less 
interparticulate bondings formed during compaction are disrupted during decompression. 
Analysis of the Heckel plots (Fig. 10) allowed to calculate several ‘in-die’ properties, 
summarized in Table 4. For each polymer type, a significantly higher Py value was noticed for 
the glassy solutions, combined with higher Db values. The Heckel yield pressure is often used 
as indication of particle plasticity (Klevan et al., 2010), while Db values represent the particle 
rearrangement in the low pressure region whereby higher Db values are indicative of materials 
with higher fragmentary nature (Tarlier et al., 2015). These values indicated that the glassy 
solutions underwent more volume reduction upon rearrangement compared to the other 
formulations because of their higher fragmentary behaviour (i.e. higher Db and Py values). As 
fragmentation resulted in smaller particle sizes (in-die), tensile strength of such formulations 
will be higher as seen in the tabletability plots (Fig. 5). As explained by Nordström et al., the 
hardness of the particles can be estimated based on Py values (Nordström et al., 2012) 
whereby the particles of the formulations included in this study were categorized as soft (i.e. 
40 MPa < Py < 80 MPa) or moderately hard (i.e. 80 MPa < Py < 200 MPa).  
 
3.4.3.  Tablet axial recovery over time  
 
Knowledge on the elastic behaviour of tableting formulations is essential to formulate 
compacts with adequate tensile strength and for the compaction process itself (e.g. capping 
issues), but it also has its value in downstream processing of tablets. The coating of tablets 
can be essential for various reasons (e.g. taste masking), but it is a major challenge for industry 
to step down from the batch-wise coating processes towards a continuous (coating) process 
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after tableting. Limited knowledge is provided on the time dependency of elastic recovery for 
tablets made of polymer formulations although this is critical information in relation to the 
(continuous) coating process. Therefore, in addition to the ‘in-die’ elastic recovery of the tablets 
(as described above), elastic recovery of the tablets was monitored ‘out-of-die’ immediately 
after ejection and after storage over 7 days for monitoring the entire recovery process of tablets 
formulated with these amorphous polymers (Fig. 11). Radial dimension changes were 
negligible compared to the axial changes, as expected since pressure is applied in axial 
direction during compression (Haware et al., 2010; Picker, 2001). 
  A similar linear relationship between elastic (axial) recovery and compaction pressure 
was noticed, but the values recorded ‘out-of-die’ were higher compared to those measured ‘in-
die’. This indicated that a substantial part of the total tablet axial recovery took place after 
ejection from the die. Tablets of glassy solutions underwent less ‘out-of-die’ axial recovery 
compared to the formulations without API, which is beneficial for the tableting process (i.e. 
reducing the risk of capping), while the differences between the neat polymers and HME 
polymers were marginal, confirming the ‘in-die’ data where HME had no impact on the elastic 
properties of the neat polymers. No significant changes in axial tablet dimensions were 
recorded after 7 days storage of SOL and VA 64 tablets, suggesting a short timeframe for 
elastic recovery which makes these polymers beneficial for usage in (continuous) coating-
processes compared to EPO tablets.    
 
3.5.    Multivariate data analysis  
In order to summarize the behaviour under compaction of all formulations in a 
comprehensive way, a multivariate approach was used where the different compaction and 
mechanical properties were combined in order to classify the formulations according to the 
contributions of individual properties. PCA has previously been used to interpret the 
mechanical behaviour of pharmaceutical materials (Roopwani et al., 2013). The two principal 
components in the current PCA accounted for 94.1% of the total variance in the dataset with 
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the first and the second principal component (PC1 and PC2) comprising 68.8% and 25.3%, 
respectively.  
Analysis of the bi-plot (Fig. 12) for both principal components (PC1 and PC2) enabled 
to cluster formulations with similar properties. In the direction of PC1, a cluster of the EPO-
formulations (left of the origin) and a cluster of SOL and VA 64 formulations (right of the origin) 
was observed. The loadings indicated that PC1 differentiated the plastic deformation potential 
of a material (represented by the plasticity factor), while it was anti-correlated with the elastic 
recovery of materials (represented by IER). Materials with a high tendency for elastic recovery 
(high IER) are located left (i.e. EPO-formulations), while the materials which deform more 
plastically (high plasticity factor) are located right of the origin. In addition, PC1 captured the 
flow-properties of materials as good flowing materials were positioned to the right. The scores 
also indicated that the glassy solutions of all polymer types were clustered at higher PC2 
values. PC2 gave information about the fragmentation behaviour of the material (i.e. high Db 
and Py values) as the glassy solutions of the polymers were identified by high PC2. Inevitable, 
these materials will show higher tensile strength at zero porosity (ߪ଴ሻ	which is also shown by 
the loadings in the bi-plot.  
The use of PCA enabled the selection of amorphous polymers which have the highest 
potential as carrier for glassy solutions with CEL in respect of tableting. This was done by 
making an imaginary arrow (Fig. 12) from the bottom left side (least favourable) of the bi-plot 
towards the upper right side (most favourable) and projecting the scores orthogonal on this 
line. In this case, SOL and VA 64 glassy solutions had the best compaction and flow properties 
making the selection of these amorphous polymers beneficial compared to EPO.  
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4.      CONCLUSIONS 
Monitoring the punch movement using the described instrumentation and CDAAS-
software was an effective tool for in-line measurement of compaction properties on a rotary 
tablet press. These compaction properties provided better insight in the compression 
mechanisms which enable the formation of strong compacts. By combining both ‘in-die’ and 
‘out-of-die’ techniques it was possible to investigate in a comprehensive way the impact of 
HME on the tableting behaviour of amorphous polymers and their formulations. While HME 
had only a limited influence on the compaction properties of the amorphous polymers when no 
drug was included, HME changed the compaction properties of glassy solutions towards a 
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more fragmentary behaviour, independent of the type of amorphous polymer. The application 
of PCA on the compaction data empowered the selection of SOL and VA 64 from the 
polymer platform as favourable amorphous polymers over EPO. This research paper 
offered a straightforward approach for the establishment of a formulation development 
platform from which researchers could select the adequate polymer for both HME and 
tableting purpose.  
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Fig. 1. Example of a force-displacement profile recorded in-line on the rotary tablet press defining the different 
phases during compression.  
 
Fig. 2. Overlay of the temperature sweep experiments on Soluplus (SOL), Kollidon VA 64 (VA 64) and Eudragit 
EPO (EPO) and their physical mixtures with CEL (35%). Complex viscosity (*) is plotted against temperature 
and the predicted extrudable range is shown ().  
 
Fig. 3. XRD-profiles of CEL (a), physical mixtures with 35% CEL for SOL (b), VA 64 (d), EPO (f) and milled 
extrudates with 35% CEL for SOL (c), VA 64 (e) and EPO (g). The patterns were re-scaled (A.U.) for comparison.  
Fig. 4. Example of FT-IR spectra for the neat SOL polymer (), physical mixture containing 35% CEL () and 
milled extrudates of the formulation with CEL (---) with wavenumbers of the specific peaks.  
Fig. 5. Tabletability profiles of the neat polymers (neat), neat polymer hot-melt extrudates (EX) and glassy 
solutions for formulations containing SOL (left), VA 64 (middle) and EPO (right).  
Fig. 6. Compressibility profiles of the neat polymers (neat), neat polymer hot-melt extrudates (EX) and glassy 
solutions for formulations containing SOL (left), VA 64 (middle) and EPO (right). 
Fig. 7. Compactibility profiles of the neat polymers (neat), neat polymer hot-melt extrudates (EX) and glassy 
solutions for formulations containing SOL (left), VA 64 (middle) and EPO (right). 
Fig. 8. Profiles of the plasticity factor in function of compaction pressure for formulations containing SOL (left), VA 
64 (middle) and EPO (right), measured in-line at the rotary tablet press.  
Fig. 9. Profiles of the measured in-die elastic recovery (IER) normalised by the compaction pressure exerted on 
the powders, measured in-line at the rotary tablet press for formulations containing SOL (left), VA 64 (middle) and 
EPO (right).   
Fig. 10. Heckel plots for SOL-formulations (left), VA64-formulations (middle) and EPO-formulations (right).  
Fig. 11. ‘Out-of-die’ axial recovery of tablets (n=3) immediately after ejection (full line,  ) and after 7 days of 
storage (point line,  ) for the neat polymers (blue), the milled extrudates (orange) and the milled glassy solutions 
(black) of Soluplus (A), Kollidon VA 64 (B) and Eudragit EPO (C).  
 
Fig. 12. PC1 vs. PC2 bi-plot of the determined compaction and flow properties for SOL formulations (blue), VA 64 
formulations (green) and EPO formulations (orange) for which the neat polymer (neat, circles), extrudates of the 
neat polymer (EX, squares) and glassy solutions containing 35% CEL (GS, triangles) are represented in function 
of the loadings (star symbols): plasticity factor (PF) and the anti-correlated ‘in-die’ elastic recovery (IER) of the 
formulations on three exerted compaction pressures (65 MPa, 190 MPa and 510 MPa), the Heckel values Db and 
Py, tablet tensile strength at zero porosity (TS_0) and the flow rate of the formulations.  
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Fig. 1. Example of a force-displacement profile recorded in-line on the rotary tablet press defining the different 
phases during compression. 
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Fig. 2. Overlay of the temperature sweep experiments on Soluplus (SOL), Kollidon VA 64 (VA 64) and Eudragit EPO 
(EPO) and their physical mixtures with CEL (35%). Complex viscosity (*) is plotted against temperature and the 
predicted extrudable range is shown ().  
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Fig. 3. XRD-profiles of CEL (a), physical mixtures with 35% CEL for SOL (b), VA 64 (d), EPO (f) and milled extrudates 
with 35% CEL for SOL (c), VA 64 (e) and EPO (g). The patterns were re-scaled (A.U.) for comparison.  
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Fig. 4. Example of FT-IR spectra for the neat SOL polymer (), physical mixture containing 35% CEL () and 
milled extrudates of the formulation with CEL (---) with wavenumbers of the specific peaks.  
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Fig. 5. Tabletability profiles of the neat polymers (neat), neat polymer hot-melt extrudates (EX) and glassy solutions for 
formulations containing SOL (left), VA 64 (middle) and EPO (right).  
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Fig. 6. Compressibility profiles of the neat polymers (neat), neat polymer hot-melt extrudates (EX) and glassy solutions for 
formulations containing SOL (left), VA 64 (middle) and EPO (right). 
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Fig. 7. Compactibility profiles of the neat polymers (neat), neat polymer hot-melt extrudates (EX) and glassy solutions for 
formulations containing SOL (left), VA 64 (middle) and EPO (right). 
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Fig. 8. Profiles of the plasticity factor in function of compaction pressure for formulations containing SOL (left), VA 64 (middle) and 
EPO (right), measured in-line at the rotary tablet press.  
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Fig. 9. Profiles of the measured in-die elastic recovery (IER) normalised by the compaction pressure exerted on the powders, 
measured in-line at the rotary tablet press for formulations containing SOL (left), VA 64 (middle) and EPO (right).   
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Fig. 10. Heckel plots for SOL-formulations (left), VA64-formulations (middle) and EPO-formulations (right). 
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Fig. 11. ‘Out-of-die’ axial recovery of tablets (n=3) immediately after ejection (full line,  ) and after 7 days of storage (point line,  ) 
for the neat polymers (blue), the milled extrudates (orange) and the milled glassy solutions (black) of Soluplus (A), Kollidon VA 64 (B)
and Eudragit EPO (C).  
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Fig. 12. PC1 vs. PC2 bi-plot of the determined compaction and flow properties for SOL formulations (blue), VA 64 formulations (green) 
and EPO formulations (orange) for which the neat polymer (neat, circles), extrudates of the neat polymer (EX, squares) and glassy 
solutions containing 35% CEL (GS, triangles) are represented in function of the loadings (star symbols): plasticity factor (PF) and the 
anti-correlated ‘in-die’ elastic recovery (IER) of the formulations on three exerted compaction pressures (65 MPa, 190 MPa and 510 
MPa), the Heckel values Db and Py, tablet tensile strength at zero porosity (TS_0) and the flow rate of the formulations.  
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Table 1. Overview of the material characterization data. Degradation temperatures (Tdeg), glass transition 
temperatures (Tg), melting points (Tm), extrudable temperature ranges based on complex viscosities (Trange 10000-1000 
Pa S) and barrel extrusion temperatures (Tex).   
 
Table 2. Overview of thermal properties (Tg & Tm) for all polymers non-processed (neat) or as physical 
mixture with CEL (PM), as extrudates (EX) and extrudates after milling (milled EX). 
Table 3.  Overview of the physical properties and powder characteristics for all formulations (values are 
expressed as mean  st. deviation). 
Table 4. Overview of the Heckel parameters (slope k and material constant A) and the derived in-die 
compaction properties (Heckel mean value Py and fragmentation factor Db).  
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Table 1. Overview of the material characterization data. Degradation temperatures (Tdeg), glass transition 
temperatures (Tg), melting points (Tm), extrudable temperature ranges based on complex viscosities (Trange 10000-1000 
Pa S) and barrel extrusion temperatures (Tex).          
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Formulation  Tdeg (°C) Tg (°C) Tm (°C) Trange 10000-1000 Pa S (°C) Tex (°C) 
CEL  242.2 58.5 ± 0.85 162.9 ± 0.89 - - 
SOL  289.2 64.2 ± 0.89 - 149 - 185 160 
SOL-CEL (35%)  - 66.6 ± 1.95 144.2 ± 0.83 138 - 167 140 
VA 64  288.9  107.9 ± 0.71 - 160 - 184 170 
VA 64-CEL (35%)  -  106.6 ± 3.55 145.4 ± 0.06 149 - 168 150 
EPO  250.5 52.5 ± 1.07 - 130 - 160 140 
EPO-CEL (35%)   - 52.8 ± 0.39 151.0 ± 3.71 112 - 140 120 
  43
 
 
 
 
 
Table 2. Overview of thermal properties (Tg & Tm) for all polymers non-processed (neat) or as physical 
mixture with CEL (PM), as extrudates (EX) and extrudates after milling (milled EX). 
 
 
Formulation        Tg  
(°C) 
Tm  
(°C) 
SOL    Neat   64.2 ± 0.89a - 
   EX  56.9 ± 1.21b - 
   Milled EX  56.8 ± 1.82b - 
SOL-CEL (35%)    PM    66.6 ± 1.95 144.2 ± 0.83 
    Milled EX    52.7 ± 1.15  - 
VA 64    Neat   107.9 ± 0.71a - 
    EX  106.6 ± 1.21a - 
    Milled EX  108.7 ± 1.15a - 
VA 64-CEL (35%)    PM   106.6 ± 3.55 145.4 ± 0.06 
    Milled EX   103.0 ± 1.16  - 
EPO    Neat  52.5 ± 1.07a - 
    EX  46.9 ± 1.74b - 
    Milled EX  45.7 ± 2.15b - 
EPO-CEL (35%)     PM    52.8 ± 0.39 151.0 ± 3.71 
    Milled EX    51.5 ± 2.47  - 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Means of Tg(a,b) with other superscript are different at the 0.05 level of significance (Tukey) (n=3).               
Means of (-) for Tm is the lack of a melting point                           
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Table 3.  Overview of the physical properties and powder characteristics for all formulations (values are 
expressed as mean  st. deviation). 
Formulation    True density 
(g/cm3) 
Moisture  
(%) 
Mean PSD  Specific surface 
area (m2/g) 
Flow rate 
(mg/s) d10 (m)  d50 (m)  d90 (m) 
SOL  Neat  1.163  0.009  2.10 ± 0.15  36.0 ± 0.5  81.4 ± 0.9  146 ± 1.2  0.172 ± 0.001       182 ± 12.0 
  Milled EX  1.164  0.001  2.10 ± 0.05  35.7 ± 1.5  81.5 ± 1.8  142 ± 2.6  0.161 ± 0.001      165 ± 4.38 
SOL‐CEL (35%)  Milled EX  1.248  0.000  ‐  10.6 ± 1.7  57.0 ± 6.6  123 ± 3.0  0.166 ± 0.002      139 ± 10.7 
VA 64  Neat  1.213  0.001  3.98 ± 0.01   18.1 ± 0.9  48.2 ± 0.3   82.6 ± 0.5  0.229 ± 0.001      46.7 ± 3.31 
  Milled EX  1.211  0.000  4.00 ± 0.06  19.8 ± 0.9  53.2 ± 0.5   94.7 ± 0.8  0.333 ± 0.003      56.9 ± 5.75 
VA 64‐CEL (35%)  Milled EX  1.262  0.000   ‐  4.34 ± 0.6  30.0 ± 4.6   104 ± 2.9  0.382 ± 0.002      61.2 ± 2.12 
EPO  Neat  1.108  0.003  0.99 ± 0.03  4.82 ± 0.1  8.85 ± 0.4  18.8 ± 4.0  1.274 ± 0.004      7.90 ± 0.39 
  Milled EX  1.085  0.004  1.02 ± 0.01  3.40 ± 0.7  8.44 ± 1.1  49.1 ± 7.0  2.507 ± 0.008      7.70 ± 1.67 
EPO‐CEL (35%)   Milled EX  1.215  0.003  ‐  7.22 ± 0.7  14.9 ± 0.7  64.8 ± 3.8  0.562 ± 0.006      15.2 ± 1.67 
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Formulation    k  
(1/MPa) 
Py  
(MPa) 
          A  Db  
 
SOL  Neat  0.022  45.42  1.43 0.952  0.0047  
  Milled EX  0.017  58.59  3.67 0.915  0.0122  
SOL‐CEL (35%)  Milled EX  0.011   96.66  1.31  0.957   0.0348  
VA 64  Neat  0.017  57.50  0.97 0.726  0.0151  
  Milled EX  0.012  80.02  1.49 0.940  0.0226  
VA 64‐CEL (35%)  Milled EX  0.011   92.49  1.17  1.072   0.0331  
EPO  Neat  0.018  55.01  2.24 0.930  0.0037  
  Milled EX  0.020  49.33  0.76 0.915  0.0150  
EPO‐CEL (35%)   Milled EX  0.012   84.68  1.20  0.952   0.0312  
Table 4. Overview of the Heckel parameters (slope k and material constant A) and the derived 
in-die compaction properties (Heckel mean value Py and fragmentation factor Db).  
